Manage COPD with these 9 Simple Tricks
There are about 16 million Americans living with chronic obstructive pulmonary disease (COPD) today. COPD is a serious medical condition that can be fatal if not treated and managed.…
Share
RedHill Biopharma Expands Opaganib COVID-19 Phase 2/3 Study with Clinical Trial Applications in Italy and UK
The multi-center, randomized, double-blind, parallel-arm, placebo-controlled Phase 2/3 clinical study with opaganib in 270 severe COVID-19 patients is planned to be conducted in up to 40…
Share
PRA Health Sciences ready to navigate RACE Act requirements for pediatric oncology
U.S. law requiring clinical research for pediatric oncology treatments goes into effect mid-August 2020 RALEIGH, N.C., June 18, 2020 (GLOBE NEWSWIRE) — Between 2007-2017, 78 novel adult…
Share
RedHill Biopharma to Present at Virtual Life Sciences Investor Forum on June 25
TEL-AVIV, Israel and RALEIGH, N.C., June 18, 2020 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today…
Share
Immunicum AB (publ) Announces Publication of Phase I/II Clinical Trial Results of Ilixadencel in Gastrointestinal Stromal Tumors (GIST) in Cancer Immunology, Immunotherapy
Press Release 16 June 2020 Immunicum AB (publ) Announces Publication of Phase I/II Clinical Trial Results of Ilixadencel in Gastrointestinal Stromal Tumors (GIST) in Cancer Immunology,…
Share
Constellation Pharmaceuticals Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., June 15, 2020 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc., (Nasdaq: CNST) a clinical-stage biopharmaceutical company using its expertise in epigenetics to…
Share
Navidea Biopharmaceuticals Announces Full Enrollment in its Ongoing Phase 2B Trial of Tc99m Tilmanocept in Rheumatoid Arthritis (RA)
DUBLIN, OH, June 15, 2020 (GLOBE NEWSWIRE) — Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision…
Share
Bellicum Receives FDA IND Clearance to Initiate a Phase 1/2 Clinical Trial for BPX-603, a Dual-Switch GoCAR-T® for HER2+ Solid Tumors
HOUSTON, June 15, 2020 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced…
Share
Immunicum AB (publ) Announces Advancement to a Non-Staggered Inclusion Phase in the Phase Ib/II ILIAD Combination Trial
Press Release 15 June 2020 Immunicum AB (publ) Announces Advancement to a Non-Staggered Inclusion Phase in the Phase Ib/II ILIAD Combination Trial Immunicum AB (publ; IMMU.ST) announced today…
Share
ProQR Announces Expert Perspectives Conference Call Series
Initial call in the series will feature Usher syndrome and retinitis pigmentosa on June 22 LEIDEN, Netherlands & CAMBRIDGE, Mass., June 12, 2020 (GLOBE NEWSWIRE) — ProQR Therapeutics…
Share